Literature DB >> 10518501

Regulation of postembryonic G(1) cell cycle progression in Caenorhabditis elegans by a cyclin D/CDK-like complex.

M Park1, M W Krause.   

Abstract

In many organisms, initiation and progression through the G(1) phase of the cell cycle requires the activity of G(1)-specific cyclins (cyclin D and cyclin E) and their associated cyclin-dependent kinases (CDK2, CDK4, CDK6). We show here that the Caenorhabditis elegans genes cyd-1 and cdk-4, encoding proteins similar to cyclin D and its cognate cyclin-dependent kinases, respectively, are necessary for proper division of postembryonic blast cells. Animals deficient for cyd-1 and/or cdk-4 activity have behavioral and developmental defects that result from the inability of the postembryonic blast cells to escape G(1) cell cycle arrest. Moreover, ectopic expression of cyd-1 and cdk-4 in transgenic animals is sufficient to activate a S-phase reporter gene. We observe no embryonic defects associated with depletion of either of these two gene products, suggesting that their essential functions are restricted to postembryonic development. We propose that the cyd-1 and cdk-4 gene products are an integral part of the developmental control of larval cell proliferation through the regulation of G(1) progression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10518501     DOI: 10.1242/dev.126.21.4849

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  36 in total

1.  Cyclin D and cdk4 are required for normal development beyond the blastula stage in sea urchin embryos.

Authors:  Jennifer C Moore; Jan L Sumerel; Bradley J Schnackenberg; Jason A Nichols; Athula Wikramanayake; Gary M Wessel; William F Marzluff
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

Review 2.  Cancer models in Caenorhabditis elegans.

Authors:  Natalia V Kirienko; Kumaran Mani; David S Fay
Journal:  Dev Dyn       Date:  2010-05       Impact factor: 3.780

3.  Transcriptional regulation by a DNA-associated form of cyclin D1.

Authors:  Frédéric Bienvenu; Benjamin Barré; Sandrine Giraud; Sylvie Avril; Olivier Coqueret
Journal:  Mol Biol Cell       Date:  2005-01-19       Impact factor: 4.138

Review 4.  Transcriptional regulation of gene expression in C. elegans.

Authors:  Valerie Reinke; Michael Krause; Peter Okkema
Journal:  WormBook       Date:  2013-06-04

5.  Cyclin E and CDK-2 regulate proliferative cell fate and cell cycle progression in the C. elegans germline.

Authors:  Paul M Fox; Valarie E Vought; Momoyo Hanazawa; Min-Ho Lee; Eleanor M Maine; Tim Schedl
Journal:  Development       Date:  2011-06       Impact factor: 6.868

6.  CDC-25.2, a C. elegans ortholog of cdc25, is essential for the progression of intestinal divisions.

Authors:  Yong-Uk Lee; Miseol Son; Jiyoung Kim; Yhong-Hee Shim; Ichiro Kawasaki
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

7.  Control of Cdc14 activity coordinates cell cycle and development in Caenorhabditis elegans.

Authors:  Sarah H Roy; Joseph E Clayton; Jenna Holmen; Eleanor Beltz; R Mako Saito
Journal:  Mech Dev       Date:  2011-06-24       Impact factor: 1.882

8.  Developmental defects observed in hypomorphic anaphase-promoting complex mutants are linked to cell cycle abnormalities.

Authors:  Diane C Shakes; Penny L Sadler; Jill M Schumacher; Maziar Abdolrasulnia; Andy Golden
Journal:  Development       Date:  2003-04       Impact factor: 6.868

Review 9.  Developmental Control of the Cell Cycle: Insights from Caenorhabditis elegans.

Authors:  Edward T Kipreos; Sander van den Heuvel
Journal:  Genetics       Date:  2019-03       Impact factor: 4.562

10.  Synthetic lethal genetic interactions that decrease somatic cell proliferation in Caenorhabditis elegans identify the alternative RFC CTF18 as a candidate cancer drug target.

Authors:  Jessica McLellan; Nigel O'Neil; Sanja Tarailo; Jan Stoepel; Jennifer Bryan; Ann Rose; Philip Hieter
Journal:  Mol Biol Cell       Date:  2009-12       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.